322 (Memantine hydrochloride 10 mg)
Pill imprint 322 has been identified as Memantine hydrochloride 10 mg.
Memantine is used in the treatment of alzheimer's disease; migraine; autism and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 322
- Strength:
- 10 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sun Pharmaceutical Industries
More about memantine
Consumer resources
- Memantine
- Memantine extended-release capsules
- Memantine solution
- Memantine tablets
- Memantine (Advanced Reading)
- Other brands: Namenda, Namenda XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
